KVUE (Kenvue) Short-Term Debt: $1,589 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KVUE Kenvue Inc KVUE
72 GF Score
Price $19.31
GF Value $20.43
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Kenvue Short-Term Debt?

Kenvue KVUE -2.43% 72 Short-Term Debt is $1,589 Mil as of Mar. 2026. GuruFocus rates KVUE with a GF Score™ of 72/100 and a GF Value™ of $20.43 (Fairly Valued). The stock has 7 warning signs investors should review.

Kenvue's Short-Term Debt for the quarter that ended in Mar. 2026 was $1,589 Mil.

Kenvue's quarterly Short-Term Debt declined from Sep. 2025 ($1,913 Mil) to Dec. 2025 ($1,453 Mil) but then increased from Dec. 2025 ($1,453 Mil) to Mar. 2026 ($1,589 Mil).

Kenvue's annual Short-Term Debt increased from Dec. 2023 ($599 Mil) to Dec. 2024 ($1,552 Mil) but then declined from Dec. 2024 ($1,552 Mil) to Dec. 2025 ($1,453 Mil).

Kenvue Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Kenvue Short-Term Debt Related Terms

Kenvue Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Kenvue's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kenvue Short-Term Debt Chart

Kenvue Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial 0.00 0.00 599.00 1,552.00 1,453.00

Kenvue Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,431.00 1,553.00 1,913.00 1,453.00 1,589.00
KVUE
72GF Score
Kenvue Inc KVUE
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $1,589 Mil mean?
Kenvue (KVUE) has a Short-Term Debt of $1,589 Mil as of Mar. 2026.
Is Kenvue's Short-Term Debt too high?
Kenvue's current Short-Term Debt is $1,589 Mil. Overall, Kenvue has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kenvue's Short-Term Debt compare to KMB and EL?
Kenvue's Short-Term Debt of $1,589 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Consumer Packaged Goods company?
A good Short-Term Debt depends on the Consumer Packaged Goods industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Kenvue's current Short-Term Debt is $1,589 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kenvue stock overvalued right now?
Based on GuruFocus' analysis, Kenvue (KVUE) is currently considered Fairly Valued. The stock's GF Value™ is $20.43, compared to a current price of $19.31 — trading 5.5% below its estimated fair value. The current Short-Term Debt is $1,589 Mil. Kenvue's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Kenvue (KVUE), the current Short-Term Debt is $1,589 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kenvue (KVUE) Overvalued in 2026?

Based on GuruFocus' analysis, Kenvue stock appears to be undervalued. The current stock price of $19.31 is trading 5.5% below its estimated GF Value™ of $20.43. GuruFocus considers Kenvue to be Fairly Valued.

Key valuation signals for KVUE:

  • Short-Term Debt: $1,589 Mil
  • GF Value™: $20.43 vs. price of $19.31 (5.5% below fair value)
  • GF Score™: 72/100 with 7 warning signs

No single metric tells the full story. See the KVUE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kenvue Business Description

Address 1 Kenvue Way, Summit, NJ, USA, 07901
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
72GF Score

Get the complete analysis for KVUE

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.31
Price
$20.43
GF Value